IL82523A - Pharmaceutical composition comprising a surface-active compound and fluorinated compound capable of emitting ionic fluorine for inhibiting or destroying a unicellular living being or virus and inhibiting or destroying an enzyme associated with the being or virus - Google Patents

Pharmaceutical composition comprising a surface-active compound and fluorinated compound capable of emitting ionic fluorine for inhibiting or destroying a unicellular living being or virus and inhibiting or destroying an enzyme associated with the being or virus

Info

Publication number
IL82523A
IL82523A IL82523A IL8252387A IL82523A IL 82523 A IL82523 A IL 82523A IL 82523 A IL82523 A IL 82523A IL 8252387 A IL8252387 A IL 8252387A IL 82523 A IL82523 A IL 82523A
Authority
IL
Israel
Prior art keywords
destroying
inhibiting
virus
living
pharmaceutical composition
Prior art date
Application number
IL82523A
Other languages
English (en)
Other versions
IL82523A0 (en
Original Assignee
Atlantic Pharma Prod
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR8607310A external-priority patent/FR2598916B1/fr
Application filed by Atlantic Pharma Prod filed Critical Atlantic Pharma Prod
Publication of IL82523A0 publication Critical patent/IL82523A0/xx
Publication of IL82523A publication Critical patent/IL82523A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/16—Fluorine compounds
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N59/00—Biocides, pest repellants or attractants, or plant growth regulators containing elements or inorganic compounds
    • A01N59/10—Fluorides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/20—Halogens; Compounds thereof
    • A61K8/21—Fluorides; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/41—Amines
    • A61K8/416—Quaternary ammonium compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/005—Antimicrobial preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Birds (AREA)
  • Plant Pathology (AREA)
  • Zoology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Agronomy & Crop Science (AREA)
  • Pest Control & Pesticides (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dentistry (AREA)
  • Wood Science & Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Environmental Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
IL82523A 1986-05-22 1987-05-14 Pharmaceutical composition comprising a surface-active compound and fluorinated compound capable of emitting ionic fluorine for inhibiting or destroying a unicellular living being or virus and inhibiting or destroying an enzyme associated with the being or virus IL82523A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8607310A FR2598916B1 (fr) 1986-05-22 1986-05-22 Compose chimique fluore utilise dans une methode de contraception locale et composition contraceptive locale fluoree, notamment spermicide
EP86402716A EP0253037B1 (fr) 1986-05-22 1986-12-08 Composition inhibitrice d'au moins un être vivant unicellulaire et/ou virus, procédé de fabrication et applications de cette composition

Publications (2)

Publication Number Publication Date
IL82523A0 IL82523A0 (en) 1987-11-30
IL82523A true IL82523A (en) 1992-05-25

Family

ID=26106166

Family Applications (1)

Application Number Title Priority Date Filing Date
IL82523A IL82523A (en) 1986-05-22 1987-05-14 Pharmaceutical composition comprising a surface-active compound and fluorinated compound capable of emitting ionic fluorine for inhibiting or destroying a unicellular living being or virus and inhibiting or destroying an enzyme associated with the being or virus

Country Status (14)

Country Link
JP (1) JP2559735B2 (xx)
CN (1) CN87103752A (xx)
AT (1) ATE64854T1 (xx)
AU (1) AU7331287A (xx)
BR (1) BR8702645A (xx)
CA (1) CA1326446C (xx)
DK (1) DK173716B1 (xx)
FI (1) FI89675C (xx)
HU (1) HUT43793A (xx)
IE (1) IE60364B1 (xx)
IL (1) IL82523A (xx)
NO (1) NO872142L (xx)
OA (1) OA08799A (xx)
WO (1) WO1987007143A1 (xx)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2620620B1 (fr) * 1987-09-22 1991-04-05 Atlantic Pharma Prod Substance inhibitrice ou destructrice d'au moins un etre vivant unicellulaire renfermant du fluor f- et du lithium li+
ATE78396T1 (de) * 1987-09-23 1992-08-15 Atlantic Pharma Prod Zusammensetzung zur hemmung oder vernichtung mindestens eines einzelligen lebewesens, enthaltend ein quaternaeres ammoniumfluorid, und verfahren zur herstellung dieses salzes.
GB8809177D0 (en) * 1988-04-19 1988-05-25 Merrell Doe Pharmaceuticals In Method of preventing aids transmission-resulting from blood transfusions
DE4236090C1 (de) * 1992-10-26 1994-01-05 Asta Medica Arzneimittel Pharmazeutische Zubereitung für die Fluoridionen-Versorgung
US5658946A (en) * 1996-05-29 1997-08-19 The Procter & Gamble Company Methods for the treatment of herpes virus infections
RU2259825C9 (ru) 2001-06-18 2006-04-10 БиоДием Лимитед Вещества, проявляющие антимикробную, антигрибковую, антипротозойную активности
JP4759104B2 (ja) * 2005-08-26 2011-08-31 株式会社ユネクス センサ保持装置
JP6204729B2 (ja) * 2013-07-10 2017-09-27 花王株式会社 水溶性ポリマー組成物
WO2015161860A1 (en) * 2014-04-25 2015-10-29 Frank Flechsig Improved biocide compositions based on calcium fluoride as well as uses thereof

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH448388A (de) * 1963-12-30 1967-12-15 Ciba Geigy Neues Zahnpflegemittel
US3647700A (en) * 1967-08-14 1972-03-07 Commodity Improvements Inc K2zrf6
US3995029A (en) * 1975-01-02 1976-11-30 Geraldine Fay Weisz Methods for the treatment of acne
US3996350A (en) * 1975-01-02 1976-12-07 Geraldine Fay Weisz Methods and compositions for alleviating fungus infections of the skin
US4097590A (en) * 1975-07-24 1978-06-27 Geraldine Fay Weisz Methods and compositions for treatment of bacterial and fungus infections of the skin
SE444112B (sv) * 1978-06-15 1986-03-24 Dental Therapeutics Ab Rengoringsmedel for dentinytor
US4368186A (en) * 1981-05-07 1983-01-11 Syntex (U.S.A.) Inc. Methods and compositions for intravaginal contraception
US4359475A (en) * 1981-12-21 1982-11-16 Syntex (U.S.A.) Inc. Thioketal substituted N-alkyl imidazoles
US4473547A (en) * 1982-11-18 1984-09-25 Johnson & Johnson Products Inc. Anticaries compositions

Also Published As

Publication number Publication date
NO872142L (no) 1987-11-23
HUT43793A (en) 1987-12-28
IL82523A0 (en) 1987-11-30
IE60364B1 (en) 1994-07-13
AU7331287A (en) 1987-11-26
DK249287A (da) 1987-11-23
FI89675B (fi) 1993-07-30
FI89675C (fi) 1993-11-10
JPS6322023A (ja) 1988-01-29
FI872253A0 (fi) 1987-05-21
JP2559735B2 (ja) 1996-12-04
BR8702645A (pt) 1988-02-23
DK249287D0 (da) 1987-05-14
FI872253A (fi) 1987-11-23
ATE64854T1 (de) 1991-07-15
CA1326446C (en) 1994-01-25
OA08799A (fr) 1989-03-31
IE871338L (en) 1987-11-22
WO1987007143A1 (fr) 1987-12-03
DK173716B1 (da) 2001-07-23
CN87103752A (zh) 1988-09-21
NO872142D0 (no) 1987-05-21

Similar Documents

Publication Publication Date Title
HUT59005A (en) Process for producing transdermal pharmaceutical preparations containing 2-amino-6-(propyl-amino)-4,5,6,7-tetrahydro-benzothiazole
DK653688D0 (da) Stabiliserede laegemiddelaktive forbindelser, fremgangsmaade til deres frmstilling samt stabile laegemiddelpraeparater
PT83872B (pt) Processo de preparacao de compostos de fosforo e de medicamentos contendo-os
DK471085D0 (da) Farmaceutiske sammensaetninger indeholdende syntetiske phospholipiderog et farmaceutisk aktivt stof samt deres fremstilling og anvendelse
PT95343A (pt) Processo para a preparacao de composicoes farmaceuticas contendo doses baixas de um agente anticoagulante oral tal como o warfarin e de um inibidor de plaquetas tal como o acido acetilsalilico,como ingredientes acticovos apropriadas para otratamento e/ou prevencao de doencas cardiacas
FR2707184B1 (fr) Procédé de préparation de sphérules contenant un principe actif alimentaire ou pharmaceutique.
PH25862A (en) IFN-gamma as an active substance for inhibiting and preventing degradation processes in bone
MX170909B (es) Procedimiento para preparar un agente para la deteccion y determinacion de actividad de peroxidasa, producto resultante y su empleo
IL82523A (en) Pharmaceutical composition comprising a surface-active compound and fluorinated compound capable of emitting ionic fluorine for inhibiting or destroying a unicellular living being or virus and inhibiting or destroying an enzyme associated with the being or virus
BR9913782A (pt) Processo de preparação de uma formualação galênica que compreende fenofibrato como princìpio ativo, formulação galênica, medicamento e utilizações de um meio lìquido e de partìculas de fenofibrato
UA39884C2 (uk) Таблетка на основі клодронової кислоти, спосіб її одержання та спосіб лікування остеопорозу
ES2041243T3 (es) Aplicacion de por lo menos un principio activo inhibidor o destructor de por lo menos un ser vivo unicelular o virus.
DE69230491T2 (de) Transformierte zellen zur verhütung oder zur behandlung von virus-induzierten erkrankungen,besonders pathogenen retroviren
MX9306607A (es) Dindihidrogeno-otorfosfato de tilidina, procedimiento para su obtencion y las preparaciones farmaceuticas que lo contienen.
ES2043351T3 (es) Preparado farmaceutico para el tratamiento de enfermedades hepaticas.
DE69026511T2 (de) Verwendung von gibberellinen zur herstellung eines arzneimittels zur behandlung von prostatitis
DE69004425T2 (de) Verwendung von c-20 bis c-26-aliphatischen alkoholen zur herstellung eines arzneimittels zur behandlung viraler infektionen.
DE68900926D1 (de) Pharmazeutische zubereitung, die zidovudin und inosiplex oder bestandteile davon enthaelt, fuer die behandlung von aids-verwandten syndromen.
DK325387A (da) 4-benzyloxy-3-pyrrolin-2-on-1-yl-acetamid samt dets fremstilling og anvendelse
DE59006307D1 (de) Badezusatz und dessen Verwendung.
FR2700268B1 (fr) Composition cosmétique ou pharmaceutique, notamment dermatologique, contenant un extrait de Vismia.
FR2647784B1 (fr) Association de vitamine a a dose physiologique et de differents principes actifs ayant une activite therapeutique
NL177404C (nl) 4-aryl-5-aminoalkyl-1,3-dioxolonen, hun farmaceutisch geschikte zouten, werkwijze voor hun bereiding, alsmede geneesmiddelen met deze dioxolonen of hun zouten als aktieve stoffen daarin.
CA2031825A1 (en) Bath additive and its use
IT1272740B (it) Composizioni farmaceutiche contenenti una sostanza attiva fosfatidilinositolo atte alla terapia delle neurpatie periferiche da diabete mellito

Legal Events

Date Code Title Description
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees